nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute and Chronic Rejection: Compartmentalization and Kinetics of Counterbalancing Signals in Cardiac Transplants
|
Kaul, A.M.K. |
|
|
15 |
2 |
p. 333-345 |
artikel |
2 |
Advances in the Understanding of Complement Mediated Glomerular Disease: Implications for Recurrence in the Transplant Setting
|
Barbour, S. |
|
|
15 |
2 |
p. 312-319 |
artikel |
3 |
American Journal of Transplantation: Volume 15, Number 2, February 2015
|
|
|
|
15 |
2 |
p. i |
artikel |
4 |
B Cell Activating Factor (BAFF) and a Proliferation Inducing Ligand (APRIL) Mediate CD40-Independent Help by Memory CD4 T Cells
|
Gorbacheva, V. |
|
|
15 |
2 |
p. 346-357 |
artikel |
5 |
B Cell Depletion at Induction—Making Bad Immunological Memory Fade?
|
Clatworthy, M.R. |
|
|
15 |
2 |
p. 297-298 |
artikel |
6 |
Bortezomib, C1-Inhibitor and Plasma Exchange Do Not Prolong the Survival of Multi-Transgenic GalT-KO Pig Kidney Xenografts in Baboons
|
Le Bas-Bernardet, S. |
|
|
15 |
2 |
p. 358-370 |
artikel |
7 |
CDC Health Advisory Regarding the Potential for Circulation of Drifted Influenza A (H3N2) Viruses
|
Blumberg, Emily A. |
|
|
15 |
2 |
p. 568 |
artikel |
8 |
Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long-Term Graft Outcome Study From the European Liver Transplant Registry
|
Adam, R. |
|
|
15 |
2 |
p. 395-406 |
artikel |
9 |
Comparison of Listing Strategies for Allosensitized Heart Transplant Candidates Requiring Transplant at High Urgency: A Decision Model Analysis
|
Feingold, B. |
|
|
15 |
2 |
p. 427-435 |
artikel |
10 |
Comparison of Longer-Term Outcomes After Kidney Transplantation Between Hispanic and Non-Hispanic Whites in the United States
|
Arce, C.M. |
|
|
15 |
2 |
p. 499-507 |
artikel |
11 |
Dramatic Improvement of Severe Cryptococcosis-Induced Immune Reconstitution Syndrome With Adalimumab in a Renal Transplant Recipient
|
Scemla, A. |
|
|
15 |
2 |
p. 560-564 |
artikel |
12 |
Early Graft Dysfunction After Lung Transplantation
|
Brown, C.R. |
|
|
15 |
2 |
p. 569-571 |
artikel |
13 |
Emerging Therapies Targeting Intra-Organ Inflammation in Transplantation
|
Solhjou, Z. |
|
|
15 |
2 |
p. 305-311 |
artikel |
14 |
Heterogeneity and Disparities in the Use of Exception Scores in Pediatric Liver Allocation
|
Hsu, E.K. |
|
|
15 |
2 |
p. 436-444 |
artikel |
15 |
High Prevalence of Hepatitis B Nonimmunity in Vaccinated Pediatric Liver Transplant Recipients
|
Leung, D.H. |
|
|
15 |
2 |
p. 535-540 |
artikel |
16 |
Inflammatory Cell Burden and Phenotype in Endomyocardial Biopsies With Antibody-Mediated Rejection (AMR): A Multicenter Pilot Study From the AECVP
|
Fedrigo, M. |
|
|
15 |
2 |
p. 526-534 |
artikel |
17 |
Laboratory Identification of Donor-Derived Coxsackievirus B3 Transmission
|
Abbott, I.J. |
|
|
15 |
2 |
p. 555-559 |
artikel |
18 |
Literature Watch Implications for transplantation
|
Perelis, Mark |
|
|
15 |
2 |
p. 293 |
artikel |
19 |
Liver, Pancreas and Kidney Transplantation for the Treatment of Wolcott–Rallison Syndrome
|
Tzakis, A.G. |
|
|
15 |
2 |
p. 565-567 |
artikel |
20 |
Liver Preservation With Machine Perfusion and a Newly Developed Cell-Free Oxygen Carrier Solution Under Subnormothermic Conditions
|
Fontes, P. |
|
|
15 |
2 |
p. 381-394 |
artikel |
21 |
Liver Transplantation With Aged Donors in Patients With Hepatitis C Virus
|
Gastaca, M. |
|
|
15 |
2 |
p. 572 |
artikel |
22 |
Liver Transplantation With Aged Donors in Patients With Hepatitis C Virus: Authors’ Reply
|
Ghinolfi, D. |
|
|
15 |
2 |
p. 573-574 |
artikel |
23 |
Loss of Pediatric Kidney Grafts During the “High–Risk Age Window”: Insights From Pediatric Liver and Simultaneous Liver–Kidney Recipients
|
Van Arendonk, K.J. |
|
|
15 |
2 |
p. 445-452 |
artikel |
24 |
Mental Health Among Living Kidney Donors: A Prospective Comparison With Matched Controls From the General Population
|
Timmerman, L. |
|
|
15 |
2 |
p. 508-517 |
artikel |
25 |
Normothermic Ex Vivo Perfusion Provides Superior Organ Preservation and Enables Viability Assessment of Hearts From DCD Donors
|
Iyer, A. |
|
|
15 |
2 |
p. 371-380 |
artikel |
26 |
Outpatient Management of Intra-Corporeal Left Ventricular Assist Device System in Children: A Multi-Center Experience
|
Schweiger, M. |
|
|
15 |
2 |
p. 453-460 |
artikel |
27 |
Pediatric Liver Transplantation: Is It Possible to Refrain From Using Exception Scores?
|
Seda-Neto, J. |
|
|
15 |
2 |
p. 303-304 |
artikel |
28 |
Quantifying Renal Allograft Loss Following Early Antibody-Mediated Rejection
|
Orandi, B.J. |
|
|
15 |
2 |
p. 489-498 |
artikel |
29 |
Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety
|
van den Hoogen, M.W.F. |
|
|
15 |
2 |
p. 407-416 |
artikel |
30 |
Role of HLA-G as a Predictive Marker of Low Risk of Chronic Rejection in Lung Transplant Recipients: A Clinical Prospective Study
|
Brugière, O. |
|
|
15 |
2 |
p. 461-471 |
artikel |
31 |
Survival in Sensitized Lung Transplant Recipients With Perioperative Desensitization
|
Tinckam, K.J. |
|
|
15 |
2 |
p. 417-426 |
artikel |
32 |
The AJT Report
|
Pullen, Lara C. |
|
|
15 |
2 |
p. 291-292 |
artikel |
33 |
The Impact of Proposed Changes in Liver Allocation Policy on Cold Ischemia Times and Organ Transportation Costs
|
DuBay, D.A. |
|
|
15 |
2 |
p. 541-546 |
artikel |
34 |
The Independent Living Donor Advocate: A Guidance Document From the American Society of Transplantation’s Living Donor Community of Practice (AST LDCOP)
|
Hays, R.E. |
|
|
15 |
2 |
p. 518-525 |
artikel |
35 |
Transfusion Transmitted Infections in Solid Organ Transplantation
|
Mezochow, A.K. |
|
|
15 |
2 |
p. 547-554 |
artikel |
36 |
Transplanting Hearts in the Highly Sensitized Pediatric Candidate: What’s a Program to Do?
|
Canter, C.E. |
|
|
15 |
2 |
p. 301-302 |
artikel |
37 |
Universal Prophylaxis or Preemptive Strategy for Cytomegalovirus Disease After Liver Transplantation: A Systematic Review and Meta-Analysis
|
Mumtaz, K. |
|
|
15 |
2 |
p. 472-481 |
artikel |
38 |
Uric Acid and the Risk of Graft Failure in Kidney Transplant Recipients: A Re-Assessment
|
Kim, E.D. |
|
|
15 |
2 |
p. 482-488 |
artikel |
39 |
UW Solution: Still the “Gold Standard” for Liver Transplantation
|
Stewart, Z.A. |
|
|
15 |
2 |
p. 295-296 |
artikel |
40 |
What is the Definition of a Clinically Relevant Donor HLA-Specific Antibody (DSA)?
|
Hachem, R.R. |
|
|
15 |
2 |
p. 299-300 |
artikel |
41 |
What’s Hot, What’s New at WTC—Basic Science
|
Bromberg, J.S. |
|
|
15 |
2 |
p. 320-326 |
artikel |
42 |
What’s Hot, What’s New at WTC—Clinical Science
|
Mueller, T.F. |
|
|
15 |
2 |
p. 327-332 |
artikel |